Last updated on September 2018

A Trial of Ibrutinib Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma


Find a site near you

Start Over

Rigshospitalet

Copenhagen, Denmark
  Connect »